Coherus Bio (NQ: CHRS )
1.350
+0.100
(+8.00%)
Streaming Delayed Price
Updated: 3:26 PM EDT, Aug 21, 2024
Add to My Watchlist
All News about Coherus Bio
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's After-Market Session
October 27, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Coherus BioSciences Announces New Employment Inducement Grants
October 24, 2023
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Coherus BioSciences's Future
October 23, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
4 Analysts Have This to Say About Coherus BioSciences
September 26, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/742616/lab-research-scientists-women-in-stem.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Coherus BioSciences
August 03, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://g.foolcdn.com/editorial/images/749999/medicine-pills-fda-approval-stamp.jpg)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](/next-assets/images/schema-image-default.png)
Earnings Preview For Coherus BioSciences
August 01, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/09/25/chrs.png?width=1200&height=800&fit=crop)
FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients
September 25, 2023
Via Benzinga
Exposures
Product Safety
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/09/25/image26.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Coherus BioSciences Announces New Employment Inducement Grants
September 22, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Coherus Completes Surface Oncology Acquisition
September 08, 2023
Via GlobeNewswire
![](https://g.foolcdn.com/editorial/images/747022/finger-about-to-press-the-delete-key-on-a-laptop-computer.jpg)
![](https://www.investors.com/wp-content/uploads/2017/08/HTI-WALLSTREET-adobe.jpg)
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
Topics
Stocks
Exposures
US Equities
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/708c21e4-7eee-4c11-b3fe-0f564a02ae22/small/surface-logo-rgb3-jpg.jpg)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
Coherus BioSciences Announces New Employment Inducement Grants
August 22, 2023
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/08/03/cummins_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/03/clorox_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 02, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://ml.globenewswire.com/media/1e7cdf14-470b-43b2-bf7a-d88d844a34ef/small/coherus-logo-r-2x-png.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.